Kanazawa University Cancer Research Institute and Kanazawa Association of Tumor Biologists will jointly hold a symposium as below.
October 29, 2019, 9:00-16:45
Memorial Hall, School of Medicine, Kanazawa University
Cancer Research Institute, Kanazawa University (KU CRI)
Kanazawa Association of Tumor Biologists
Nano Life Science Institute, Kanazawa University (WPI-NanoLSI)
Institute for Frontier Science Initiative, Kanazawa University (InFiniti), etc.
9:00‐9:10 Opening Remarks
Atsushi Hirao, Director of KU CRI and Principal Investigator of WPI-NanoLSI, Kanazawa University
Chair: Takeshi Suzuki, KU CRI and InFiniti
9:10-9:35 Targeting mitochondrial enzumes of one-carbon metabolism for cancer treatment
Tatsunori Nishimura, KU CRI
9:35-10:00 RB1 inactivation induces a protumoral microenvironment
Chiaki Takahashi, KU CRI
10:00-10:30 Genomic and Epigenomic Alterations in Gastrointestinal Cancer: Opportunitites for Precision Oncology
Patrik Tan, Duke-NUS Medical School, Singapore
10:30-10:40 Coffee Break
Chair: Naofumi Mukaida, KU CRI
10:40-11:05 Regulation of hematopoietic stem cell fate by gut microbiota-derived metabolites
Yuko Tadokoro, KU CRI and WPI-NanoLSI
11:05-11:30 Macrocyclic peptide targeting growth factor and the receptor
Kunio Matsumoto, KU CRI, WPI-NanoLSI, and InFiniti
11:30-12:00 The potential role of multi-drug resistance protein ABCB1 for tumor suppression in bats.
Koji Itahana, Duke-NUS Medical School, Singapore
Chair: Masanobu Oshima, KU CRI and WPI-NanoLSI
13:00-13:50 Drugging the Wnt pathway – Where it helps, and what it teaches us.
David Virshup, Duke-NUS Medical School, Singapore
13:50-14:00 Coffee Break
Chair: Toshinari Minamoto, KU CRI
14:00-14:25 Protective role of JLP-dependent lysosomme positioning in reactive oxygen species (ROS)-induced cell death
I Ketut Gunarta, KU CRI
14:25-14:50 Circumvention of targeted drug tolerance in lung cancer
Seiji Yano, KU CRI and WPI-NanoLSI
14:50-15:20 The polycomb repressive complex drives epigenetic convergence in blast crisis chronic myeloid leukemia
S. Tiong Ong, Duke-NUS Medical School, Singapore
15:20-15:35 Coffee Break
15:35-16:00 CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functinoal validation for colorectal cancer driver genes.
Haruna Takeda, National Cancer Center Japan
16:00-16:25 The mechanism and physiological significance of programmed cell death initiated by caspase-1
Kohsuke Tsuchiya, KU CRI and InFiniti
16:25-16:35 External Panel Review
16:35-16:45 Closing Remarks
Chisato Mukai, Vice President of Kanazawa University
16:45-16:50 Photo session
Poster can be downloaded from here.